Chandan Basho - 05 Mar 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
05 Mar 2025
Net transactions value
$0
Form type
4
Filing time
07 Mar 2025, 20:05:17 UTC
Previous filing
12 Nov 2024
Next filing
03 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Award $0 +26,701 +16% $0.000000 192,752 05 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on September 5, 2025.
F2 Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,427 shares, which will vest in two equal annual installments on April 14, 2025 and 2026; (ii) 4,561 shares, which will vest on May 16, 2025; and (iii) 45,606 shares, which will vest in three equal annual installments on May 16, 2025, 2026 and 2027. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 27,303 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 2, 2025; and (ii) 26,701 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025.